Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 1, 2011, Pages 208-212

  Karthikeyan, K ^a,b   Arularasu, G T ^a   Murali, V ^a   Chandrasekara Pillai, K ^b  

^a Shasun Research Center   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

HPLC UV detection; Identification; Isolation; Meprobamate; Process related impurity

Indexed keywords

CARBAMIC ACID 2 CARBAMOYLOXYMETHYL 2 METHYL PENT 3 ENYL ESTER; ESTER DERIVATIVE; MEPROBAMATE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ANALYSIS; DRUG DEGRADATION; DRUG IDENTIFICATION; DRUG IMPURITY; DRUG ISOLATION; DRUG RETENTION; DRUG SPECIFICITY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ALKENES; CALIBRATION; CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MEPROBAMATE; MODELS, CHEMICAL; OXYGEN; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; ULTRAVIOLET RAYS;

EID: 77957041356     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.018     Document Type: Article

References (25)

1. Merck & Co., Inc., The Merck Index, 14th ed., NJ, USA, 2006, p. 1013.
2. British Pharmacopoeia Commission, BP2010, London, 2010, pp. 1363-1364.
3. EDQM, European Pharmacopoeia 6.0, France, p. 2359.
4. US Pharmacopeial Convention, USP32 NF27, 2009, pp. 2887-2889, 733-736.
5. Shearer C., Rulon P. Analytical Profiles of Drug Substances 1972, vol. 1. Academic Press, NY, pp. 207-232.
6. Zappala A.F. Alex post. Rapid near IR spectrophotometric determination of meprobamate in pharmaceutical preparations. J. Pharm. Sci. 1977, 66:292-293.
7. Turczan J.W., Kram T.C. Determination of meprobamate in tablets by NMR. J. Pharm. Sci. 1967, 56:1643-1645.
8. Rabinowitz M.P., Reisberg P., Bodin J.I. GLC assay of meprobamate and related carbamates. J. Pharm. Sci. 1972, 61:1974-1976.
9. Thierry T., Denis L., Herve M., Richard V., Henri C. Gas chromatographic determination of meprobamate in human plasma. J. Chromatogr.: Biomed. Appl. 1993, 615:343-346.
10. Mortis L., Levy R.H. GLC determination of meprobamate in water, plasma and urine. J. Pharm. Sci. 1974, 63:834-837.
11. Gaillard Y., Gay-Montchamp J.P., Ollagnier M. Gas chromatographic determination of meprobamate in serum or plasma after solid-phase extraction. J. Chromatogr.: Biomed. Appl. 1992, 577:171-173.
12. Cullen L.F., Heckman L.J., Papariello G.J. Automated colorimetric method for the determination of meprobamate and other N-unsubstituted carbamate in pharmaceutical products. J. Pharm. Sci. 1969, 58:1537-1539.
13. Poole J.W., Irwin G.M., Young S. Colorimetric assay procedure for dissolution studies of meprobamate formulations. J. Pharm. Sci. 1971, 60:1850.
14. Gupta R.N., Eng F. GC and HPLC determination of meprobamate in plasma. J. High Resolution Chromatogr. Chromatogr. Commun. 1980, 3:419-420.
15. Bechet I., Ceccato A., Hubert P.H., Herne P., Crommen J. Determination of meprobamate in pharmaceutical dosage forms also containing carbromal by liquid chromatography and indirect photometric detection. J. Pharm. Biomed. Anal. 1992, 10:995-999.
16. Kintz P., Mangin P. Determination of meprobamate in human plasma, urine and hair by gas chromatography and electron impact mass spectrometry. J. Anal. Toxicol. 1993, 17:408-410.
17. Sandrine D., Damien R., Bertrand S., Alain E., Francois C. A one-step and sensitive GC-MS assay for meprobamate determination in emergency situations. J. Anal. Toxicol. 2006, 30:302-305.
18. Honigberg I.L., Stewart J.T., Smith M. Liquid chromatography in pharmaceutical analysis IX: determination of muscle relaxant-analgesic mixtures using normal phase chromatography. J. Pharm. Sci. 1978, 67:675-679.
19. Lawrence R.C., Lovering E.G., Poirier M.A., Watson J.R. Impurities in drugs V: meprobamate. J. Pharm. Sci. 1980, 69:1444-1445.
20. Karthikeyan K., Balaji T.S., Shanmugasundaram P., Chandrasekara Pillai K. Stability-indicating HPLC method for the determination of impurities in meprobamate with refractive index detection. J. Chromatogr. Sci. 2010, 48:212-218.
21. ICH, Impurities in New Drug Substances, Q3A [R2], Step 5, ICH, 2006.
22. U.S.FDA, Impurities in Drug Substances, 2000.
23. EMEA, Impurities in New Drug Substances, CPMP/ICH/2737/99, 2006.
24. ICH, Validation of Analytical Procedures, Q2 [R1], Step 5, 2005.
25. Krull I., Swartz M. Determining specificity in a regulated environment. LC-GC 2001, 19:604-614.